Service & Software
Global Supplement CDMO Market Research Report 2025
- Jun 11, 25
- ID: 300813
- Pages: 84
- Figures: 86
- Views: 5
The global market for Supplement CDMO was valued at US$ 12010 million in the year 2024 and is projected to reach a revised size of US$ 18660 million by 2031, growing at a CAGR of 6.5% during the forecast period.
Supplement CDMO refers to a professional organization that provides one-stop outsourcing services such as R&D, formula optimization, clinical trial support, large-scale production and packaging for health products (such as dietary supplements, functional foods, nutritional preparations, etc.). This model helps brands reduce R&D investment, accelerate product launch, and meet compliance requirements in the global market.
North American market for Supplement CDMO is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Supplement CDMO is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Supplement CDMO in Solid Dosage Form is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Supplement CDMO include Biofarma Group, SFI Health Solutions, TCI Bio, Lonza, HERMES PHARMA, AGC Biologics, Vitaquest, Catalent, KD Pharma Group, Pharma Tech Industries, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Supplement CDMO, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Supplement CDMO.
The Supplement CDMO market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Supplement CDMO market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Supplement CDMO companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Biofarma Group
SFI Health Solutions
TCI Bio
Lonza
HERMES PHARMA
AGC Biologics
Vitaquest
Catalent
KD Pharma Group
Pharma Tech Industries
CordenPharma
Pierre Fabre
NutraPak USA
American Health Formulations
Alora Pharmaceuticals
Segment by Type
Small Molecule CDMO
Large Molecule CDMO
Segment by Application
Solid Dosage Form
Liquid Dosage Form
Powder
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Supplement CDMO company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Supplement CDMO refers to a professional organization that provides one-stop outsourcing services such as R&D, formula optimization, clinical trial support, large-scale production and packaging for health products (such as dietary supplements, functional foods, nutritional preparations, etc.). This model helps brands reduce R&D investment, accelerate product launch, and meet compliance requirements in the global market.
North American market for Supplement CDMO is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Supplement CDMO is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Supplement CDMO in Solid Dosage Form is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Supplement CDMO include Biofarma Group, SFI Health Solutions, TCI Bio, Lonza, HERMES PHARMA, AGC Biologics, Vitaquest, Catalent, KD Pharma Group, Pharma Tech Industries, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Supplement CDMO, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Supplement CDMO.
The Supplement CDMO market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Supplement CDMO market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Supplement CDMO companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Biofarma Group
SFI Health Solutions
TCI Bio
Lonza
HERMES PHARMA
AGC Biologics
Vitaquest
Catalent
KD Pharma Group
Pharma Tech Industries
CordenPharma
Pierre Fabre
NutraPak USA
American Health Formulations
Alora Pharmaceuticals
Segment by Type
Small Molecule CDMO
Large Molecule CDMO
Segment by Application
Solid Dosage Form
Liquid Dosage Form
Powder
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Supplement CDMO company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Supplement CDMO Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Small Molecule CDMO
1.2.3 Large Molecule CDMO
1.3 Market by Application
1.3.1 Global Supplement CDMO Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Solid Dosage Form
1.3.3 Liquid Dosage Form
1.3.4 Powder
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Supplement CDMO Market Perspective (2020-2031)
2.2 Global Supplement CDMO Growth Trends by Region
2.2.1 Global Supplement CDMO Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Supplement CDMO Historic Market Size by Region (2020-2025)
2.2.3 Supplement CDMO Forecasted Market Size by Region (2026-2031)
2.3 Supplement CDMO Market Dynamics
2.3.1 Supplement CDMO Industry Trends
2.3.2 Supplement CDMO Market Drivers
2.3.3 Supplement CDMO Market Challenges
2.3.4 Supplement CDMO Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Supplement CDMO Players by Revenue
3.1.1 Global Top Supplement CDMO Players by Revenue (2020-2025)
3.1.2 Global Supplement CDMO Revenue Market Share by Players (2020-2025)
3.2 Global Top Supplement CDMO Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Supplement CDMO Revenue
3.4 Global Supplement CDMO Market Concentration Ratio
3.4.1 Global Supplement CDMO Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Supplement CDMO Revenue in 2024
3.5 Global Key Players of Supplement CDMO Head office and Area Served
3.6 Global Key Players of Supplement CDMO, Product and Application
3.7 Global Key Players of Supplement CDMO, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Supplement CDMO Breakdown Data by Type
4.1 Global Supplement CDMO Historic Market Size by Type (2020-2025)
4.2 Global Supplement CDMO Forecasted Market Size by Type (2026-2031)
5 Supplement CDMO Breakdown Data by Application
5.1 Global Supplement CDMO Historic Market Size by Application (2020-2025)
5.2 Global Supplement CDMO Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Supplement CDMO Market Size (2020-2031)
6.2 North America Supplement CDMO Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Supplement CDMO Market Size by Country (2020-2025)
6.4 North America Supplement CDMO Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Supplement CDMO Market Size (2020-2031)
7.2 Europe Supplement CDMO Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Supplement CDMO Market Size by Country (2020-2025)
7.4 Europe Supplement CDMO Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Supplement CDMO Market Size (2020-2031)
8.2 Asia-Pacific Supplement CDMO Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Supplement CDMO Market Size by Region (2020-2025)
8.4 Asia-Pacific Supplement CDMO Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Supplement CDMO Market Size (2020-2031)
9.2 Latin America Supplement CDMO Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Supplement CDMO Market Size by Country (2020-2025)
9.4 Latin America Supplement CDMO Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Supplement CDMO Market Size (2020-2031)
10.2 Middle East & Africa Supplement CDMO Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Supplement CDMO Market Size by Country (2020-2025)
10.4 Middle East & Africa Supplement CDMO Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Biofarma Group
11.1.1 Biofarma Group Company Details
11.1.2 Biofarma Group Business Overview
11.1.3 Biofarma Group Supplement CDMO Introduction
11.1.4 Biofarma Group Revenue in Supplement CDMO Business (2020-2025)
11.1.5 Biofarma Group Recent Development
11.2 SFI Health Solutions
11.2.1 SFI Health Solutions Company Details
11.2.2 SFI Health Solutions Business Overview
11.2.3 SFI Health Solutions Supplement CDMO Introduction
11.2.4 SFI Health Solutions Revenue in Supplement CDMO Business (2020-2025)
11.2.5 SFI Health Solutions Recent Development
11.3 TCI Bio
11.3.1 TCI Bio Company Details
11.3.2 TCI Bio Business Overview
11.3.3 TCI Bio Supplement CDMO Introduction
11.3.4 TCI Bio Revenue in Supplement CDMO Business (2020-2025)
11.3.5 TCI Bio Recent Development
11.4 Lonza
11.4.1 Lonza Company Details
11.4.2 Lonza Business Overview
11.4.3 Lonza Supplement CDMO Introduction
11.4.4 Lonza Revenue in Supplement CDMO Business (2020-2025)
11.4.5 Lonza Recent Development
11.5 HERMES PHARMA
11.5.1 HERMES PHARMA Company Details
11.5.2 HERMES PHARMA Business Overview
11.5.3 HERMES PHARMA Supplement CDMO Introduction
11.5.4 HERMES PHARMA Revenue in Supplement CDMO Business (2020-2025)
11.5.5 HERMES PHARMA Recent Development
11.6 AGC Biologics
11.6.1 AGC Biologics Company Details
11.6.2 AGC Biologics Business Overview
11.6.3 AGC Biologics Supplement CDMO Introduction
11.6.4 AGC Biologics Revenue in Supplement CDMO Business (2020-2025)
11.6.5 AGC Biologics Recent Development
11.7 Vitaquest
11.7.1 Vitaquest Company Details
11.7.2 Vitaquest Business Overview
11.7.3 Vitaquest Supplement CDMO Introduction
11.7.4 Vitaquest Revenue in Supplement CDMO Business (2020-2025)
11.7.5 Vitaquest Recent Development
11.8 Catalent
11.8.1 Catalent Company Details
11.8.2 Catalent Business Overview
11.8.3 Catalent Supplement CDMO Introduction
11.8.4 Catalent Revenue in Supplement CDMO Business (2020-2025)
11.8.5 Catalent Recent Development
11.9 KD Pharma Group
11.9.1 KD Pharma Group Company Details
11.9.2 KD Pharma Group Business Overview
11.9.3 KD Pharma Group Supplement CDMO Introduction
11.9.4 KD Pharma Group Revenue in Supplement CDMO Business (2020-2025)
11.9.5 KD Pharma Group Recent Development
11.10 Pharma Tech Industries
11.10.1 Pharma Tech Industries Company Details
11.10.2 Pharma Tech Industries Business Overview
11.10.3 Pharma Tech Industries Supplement CDMO Introduction
11.10.4 Pharma Tech Industries Revenue in Supplement CDMO Business (2020-2025)
11.10.5 Pharma Tech Industries Recent Development
11.11 CordenPharma
11.11.1 CordenPharma Company Details
11.11.2 CordenPharma Business Overview
11.11.3 CordenPharma Supplement CDMO Introduction
11.11.4 CordenPharma Revenue in Supplement CDMO Business (2020-2025)
11.11.5 CordenPharma Recent Development
11.12 Pierre Fabre
11.12.1 Pierre Fabre Company Details
11.12.2 Pierre Fabre Business Overview
11.12.3 Pierre Fabre Supplement CDMO Introduction
11.12.4 Pierre Fabre Revenue in Supplement CDMO Business (2020-2025)
11.12.5 Pierre Fabre Recent Development
11.13 NutraPak USA
11.13.1 NutraPak USA Company Details
11.13.2 NutraPak USA Business Overview
11.13.3 NutraPak USA Supplement CDMO Introduction
11.13.4 NutraPak USA Revenue in Supplement CDMO Business (2020-2025)
11.13.5 NutraPak USA Recent Development
11.14 American Health Formulations
11.14.1 American Health Formulations Company Details
11.14.2 American Health Formulations Business Overview
11.14.3 American Health Formulations Supplement CDMO Introduction
11.14.4 American Health Formulations Revenue in Supplement CDMO Business (2020-2025)
11.14.5 American Health Formulations Recent Development
11.15 Alora Pharmaceuticals
11.15.1 Alora Pharmaceuticals Company Details
11.15.2 Alora Pharmaceuticals Business Overview
11.15.3 Alora Pharmaceuticals Supplement CDMO Introduction
11.15.4 Alora Pharmaceuticals Revenue in Supplement CDMO Business (2020-2025)
11.15.5 Alora Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Supplement CDMO Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Small Molecule CDMO
1.2.3 Large Molecule CDMO
1.3 Market by Application
1.3.1 Global Supplement CDMO Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Solid Dosage Form
1.3.3 Liquid Dosage Form
1.3.4 Powder
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Supplement CDMO Market Perspective (2020-2031)
2.2 Global Supplement CDMO Growth Trends by Region
2.2.1 Global Supplement CDMO Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Supplement CDMO Historic Market Size by Region (2020-2025)
2.2.3 Supplement CDMO Forecasted Market Size by Region (2026-2031)
2.3 Supplement CDMO Market Dynamics
2.3.1 Supplement CDMO Industry Trends
2.3.2 Supplement CDMO Market Drivers
2.3.3 Supplement CDMO Market Challenges
2.3.4 Supplement CDMO Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Supplement CDMO Players by Revenue
3.1.1 Global Top Supplement CDMO Players by Revenue (2020-2025)
3.1.2 Global Supplement CDMO Revenue Market Share by Players (2020-2025)
3.2 Global Top Supplement CDMO Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Supplement CDMO Revenue
3.4 Global Supplement CDMO Market Concentration Ratio
3.4.1 Global Supplement CDMO Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Supplement CDMO Revenue in 2024
3.5 Global Key Players of Supplement CDMO Head office and Area Served
3.6 Global Key Players of Supplement CDMO, Product and Application
3.7 Global Key Players of Supplement CDMO, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Supplement CDMO Breakdown Data by Type
4.1 Global Supplement CDMO Historic Market Size by Type (2020-2025)
4.2 Global Supplement CDMO Forecasted Market Size by Type (2026-2031)
5 Supplement CDMO Breakdown Data by Application
5.1 Global Supplement CDMO Historic Market Size by Application (2020-2025)
5.2 Global Supplement CDMO Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Supplement CDMO Market Size (2020-2031)
6.2 North America Supplement CDMO Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Supplement CDMO Market Size by Country (2020-2025)
6.4 North America Supplement CDMO Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Supplement CDMO Market Size (2020-2031)
7.2 Europe Supplement CDMO Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Supplement CDMO Market Size by Country (2020-2025)
7.4 Europe Supplement CDMO Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Supplement CDMO Market Size (2020-2031)
8.2 Asia-Pacific Supplement CDMO Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Supplement CDMO Market Size by Region (2020-2025)
8.4 Asia-Pacific Supplement CDMO Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Supplement CDMO Market Size (2020-2031)
9.2 Latin America Supplement CDMO Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Supplement CDMO Market Size by Country (2020-2025)
9.4 Latin America Supplement CDMO Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Supplement CDMO Market Size (2020-2031)
10.2 Middle East & Africa Supplement CDMO Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Supplement CDMO Market Size by Country (2020-2025)
10.4 Middle East & Africa Supplement CDMO Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Biofarma Group
11.1.1 Biofarma Group Company Details
11.1.2 Biofarma Group Business Overview
11.1.3 Biofarma Group Supplement CDMO Introduction
11.1.4 Biofarma Group Revenue in Supplement CDMO Business (2020-2025)
11.1.5 Biofarma Group Recent Development
11.2 SFI Health Solutions
11.2.1 SFI Health Solutions Company Details
11.2.2 SFI Health Solutions Business Overview
11.2.3 SFI Health Solutions Supplement CDMO Introduction
11.2.4 SFI Health Solutions Revenue in Supplement CDMO Business (2020-2025)
11.2.5 SFI Health Solutions Recent Development
11.3 TCI Bio
11.3.1 TCI Bio Company Details
11.3.2 TCI Bio Business Overview
11.3.3 TCI Bio Supplement CDMO Introduction
11.3.4 TCI Bio Revenue in Supplement CDMO Business (2020-2025)
11.3.5 TCI Bio Recent Development
11.4 Lonza
11.4.1 Lonza Company Details
11.4.2 Lonza Business Overview
11.4.3 Lonza Supplement CDMO Introduction
11.4.4 Lonza Revenue in Supplement CDMO Business (2020-2025)
11.4.5 Lonza Recent Development
11.5 HERMES PHARMA
11.5.1 HERMES PHARMA Company Details
11.5.2 HERMES PHARMA Business Overview
11.5.3 HERMES PHARMA Supplement CDMO Introduction
11.5.4 HERMES PHARMA Revenue in Supplement CDMO Business (2020-2025)
11.5.5 HERMES PHARMA Recent Development
11.6 AGC Biologics
11.6.1 AGC Biologics Company Details
11.6.2 AGC Biologics Business Overview
11.6.3 AGC Biologics Supplement CDMO Introduction
11.6.4 AGC Biologics Revenue in Supplement CDMO Business (2020-2025)
11.6.5 AGC Biologics Recent Development
11.7 Vitaquest
11.7.1 Vitaquest Company Details
11.7.2 Vitaquest Business Overview
11.7.3 Vitaquest Supplement CDMO Introduction
11.7.4 Vitaquest Revenue in Supplement CDMO Business (2020-2025)
11.7.5 Vitaquest Recent Development
11.8 Catalent
11.8.1 Catalent Company Details
11.8.2 Catalent Business Overview
11.8.3 Catalent Supplement CDMO Introduction
11.8.4 Catalent Revenue in Supplement CDMO Business (2020-2025)
11.8.5 Catalent Recent Development
11.9 KD Pharma Group
11.9.1 KD Pharma Group Company Details
11.9.2 KD Pharma Group Business Overview
11.9.3 KD Pharma Group Supplement CDMO Introduction
11.9.4 KD Pharma Group Revenue in Supplement CDMO Business (2020-2025)
11.9.5 KD Pharma Group Recent Development
11.10 Pharma Tech Industries
11.10.1 Pharma Tech Industries Company Details
11.10.2 Pharma Tech Industries Business Overview
11.10.3 Pharma Tech Industries Supplement CDMO Introduction
11.10.4 Pharma Tech Industries Revenue in Supplement CDMO Business (2020-2025)
11.10.5 Pharma Tech Industries Recent Development
11.11 CordenPharma
11.11.1 CordenPharma Company Details
11.11.2 CordenPharma Business Overview
11.11.3 CordenPharma Supplement CDMO Introduction
11.11.4 CordenPharma Revenue in Supplement CDMO Business (2020-2025)
11.11.5 CordenPharma Recent Development
11.12 Pierre Fabre
11.12.1 Pierre Fabre Company Details
11.12.2 Pierre Fabre Business Overview
11.12.3 Pierre Fabre Supplement CDMO Introduction
11.12.4 Pierre Fabre Revenue in Supplement CDMO Business (2020-2025)
11.12.5 Pierre Fabre Recent Development
11.13 NutraPak USA
11.13.1 NutraPak USA Company Details
11.13.2 NutraPak USA Business Overview
11.13.3 NutraPak USA Supplement CDMO Introduction
11.13.4 NutraPak USA Revenue in Supplement CDMO Business (2020-2025)
11.13.5 NutraPak USA Recent Development
11.14 American Health Formulations
11.14.1 American Health Formulations Company Details
11.14.2 American Health Formulations Business Overview
11.14.3 American Health Formulations Supplement CDMO Introduction
11.14.4 American Health Formulations Revenue in Supplement CDMO Business (2020-2025)
11.14.5 American Health Formulations Recent Development
11.15 Alora Pharmaceuticals
11.15.1 Alora Pharmaceuticals Company Details
11.15.2 Alora Pharmaceuticals Business Overview
11.15.3 Alora Pharmaceuticals Supplement CDMO Introduction
11.15.4 Alora Pharmaceuticals Revenue in Supplement CDMO Business (2020-2025)
11.15.5 Alora Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Supplement CDMO Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Small Molecule CDMO
Table 3. Key Players of Large Molecule CDMO
Table 4. Global Supplement CDMO Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Supplement CDMO Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Supplement CDMO Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Supplement CDMO Market Share by Region (2020-2025)
Table 8. Global Supplement CDMO Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Supplement CDMO Market Share by Region (2026-2031)
Table 10. Supplement CDMO Market Trends
Table 11. Supplement CDMO Market Drivers
Table 12. Supplement CDMO Market Challenges
Table 13. Supplement CDMO Market Restraints
Table 14. Global Supplement CDMO Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Supplement CDMO Market Share by Players (2020-2025)
Table 16. Global Top Supplement CDMO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Supplement CDMO as of 2024)
Table 17. Ranking of Global Top Supplement CDMO Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Supplement CDMO Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Supplement CDMO, Headquarters and Area Served
Table 20. Global Key Players of Supplement CDMO, Product and Application
Table 21. Global Key Players of Supplement CDMO, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Supplement CDMO Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Supplement CDMO Revenue Market Share by Type (2020-2025)
Table 25. Global Supplement CDMO Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Supplement CDMO Revenue Market Share by Type (2026-2031)
Table 27. Global Supplement CDMO Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Supplement CDMO Revenue Market Share by Application (2020-2025)
Table 29. Global Supplement CDMO Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Supplement CDMO Revenue Market Share by Application (2026-2031)
Table 31. North America Supplement CDMO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Supplement CDMO Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Supplement CDMO Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Supplement CDMO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Supplement CDMO Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Supplement CDMO Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Supplement CDMO Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Supplement CDMO Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Supplement CDMO Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Supplement CDMO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Supplement CDMO Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Supplement CDMO Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Supplement CDMO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Supplement CDMO Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Supplement CDMO Market Size by Country (2026-2031) & (US$ Million)
Table 46. Biofarma Group Company Details
Table 47. Biofarma Group Business Overview
Table 48. Biofarma Group Supplement CDMO Product
Table 49. Biofarma Group Revenue in Supplement CDMO Business (2020-2025) & (US$ Million)
Table 50. Biofarma Group Recent Development
Table 51. SFI Health Solutions Company Details
Table 52. SFI Health Solutions Business Overview
Table 53. SFI Health Solutions Supplement CDMO Product
Table 54. SFI Health Solutions Revenue in Supplement CDMO Business (2020-2025) & (US$ Million)
Table 55. SFI Health Solutions Recent Development
Table 56. TCI Bio Company Details
Table 57. TCI Bio Business Overview
Table 58. TCI Bio Supplement CDMO Product
Table 59. TCI Bio Revenue in Supplement CDMO Business (2020-2025) & (US$ Million)
Table 60. TCI Bio Recent Development
Table 61. Lonza Company Details
Table 62. Lonza Business Overview
Table 63. Lonza Supplement CDMO Product
Table 64. Lonza Revenue in Supplement CDMO Business (2020-2025) & (US$ Million)
Table 65. Lonza Recent Development
Table 66. HERMES PHARMA Company Details
Table 67. HERMES PHARMA Business Overview
Table 68. HERMES PHARMA Supplement CDMO Product
Table 69. HERMES PHARMA Revenue in Supplement CDMO Business (2020-2025) & (US$ Million)
Table 70. HERMES PHARMA Recent Development
Table 71. AGC Biologics Company Details
Table 72. AGC Biologics Business Overview
Table 73. AGC Biologics Supplement CDMO Product
Table 74. AGC Biologics Revenue in Supplement CDMO Business (2020-2025) & (US$ Million)
Table 75. AGC Biologics Recent Development
Table 76. Vitaquest Company Details
Table 77. Vitaquest Business Overview
Table 78. Vitaquest Supplement CDMO Product
Table 79. Vitaquest Revenue in Supplement CDMO Business (2020-2025) & (US$ Million)
Table 80. Vitaquest Recent Development
Table 81. Catalent Company Details
Table 82. Catalent Business Overview
Table 83. Catalent Supplement CDMO Product
Table 84. Catalent Revenue in Supplement CDMO Business (2020-2025) & (US$ Million)
Table 85. Catalent Recent Development
Table 86. KD Pharma Group Company Details
Table 87. KD Pharma Group Business Overview
Table 88. KD Pharma Group Supplement CDMO Product
Table 89. KD Pharma Group Revenue in Supplement CDMO Business (2020-2025) & (US$ Million)
Table 90. KD Pharma Group Recent Development
Table 91. Pharma Tech Industries Company Details
Table 92. Pharma Tech Industries Business Overview
Table 93. Pharma Tech Industries Supplement CDMO Product
Table 94. Pharma Tech Industries Revenue in Supplement CDMO Business (2020-2025) & (US$ Million)
Table 95. Pharma Tech Industries Recent Development
Table 96. CordenPharma Company Details
Table 97. CordenPharma Business Overview
Table 98. CordenPharma Supplement CDMO Product
Table 99. CordenPharma Revenue in Supplement CDMO Business (2020-2025) & (US$ Million)
Table 100. CordenPharma Recent Development
Table 101. Pierre Fabre Company Details
Table 102. Pierre Fabre Business Overview
Table 103. Pierre Fabre Supplement CDMO Product
Table 104. Pierre Fabre Revenue in Supplement CDMO Business (2020-2025) & (US$ Million)
Table 105. Pierre Fabre Recent Development
Table 106. NutraPak USA Company Details
Table 107. NutraPak USA Business Overview
Table 108. NutraPak USA Supplement CDMO Product
Table 109. NutraPak USA Revenue in Supplement CDMO Business (2020-2025) & (US$ Million)
Table 110. NutraPak USA Recent Development
Table 111. American Health Formulations Company Details
Table 112. American Health Formulations Business Overview
Table 113. American Health Formulations Supplement CDMO Product
Table 114. American Health Formulations Revenue in Supplement CDMO Business (2020-2025) & (US$ Million)
Table 115. American Health Formulations Recent Development
Table 116. Alora Pharmaceuticals Company Details
Table 117. Alora Pharmaceuticals Business Overview
Table 118. Alora Pharmaceuticals Supplement CDMO Product
Table 119. Alora Pharmaceuticals Revenue in Supplement CDMO Business (2020-2025) & (US$ Million)
Table 120. Alora Pharmaceuticals Recent Development
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
Table 124. Authors List of This Report
List of Figures
Figure 1. Supplement CDMO Picture
Figure 2. Global Supplement CDMO Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Supplement CDMO Market Share by Type: 2024 VS 2031
Figure 4. Small Molecule CDMO Features
Figure 5. Large Molecule CDMO Features
Figure 6. Global Supplement CDMO Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Supplement CDMO Market Share by Application: 2024 VS 2031
Figure 8. Solid Dosage Form Case Studies
Figure 9. Liquid Dosage Form Case Studies
Figure 10. Powder Case Studies
Figure 11. Others Case Studies
Figure 12. Supplement CDMO Report Years Considered
Figure 13. Global Supplement CDMO Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global Supplement CDMO Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Supplement CDMO Market Share by Region: 2024 VS 2031
Figure 16. Global Supplement CDMO Market Share by Players in 2024
Figure 17. Global Supplement CDMO Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 18. The Top 10 and 5 Players Market Share by Supplement CDMO Revenue in 2024
Figure 19. North America Supplement CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America Supplement CDMO Market Share by Country (2020-2031)
Figure 21. United States Supplement CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada Supplement CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Supplement CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Supplement CDMO Market Share by Country (2020-2031)
Figure 25. Germany Supplement CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France Supplement CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. Supplement CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy Supplement CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia Supplement CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Nordic Countries Supplement CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Supplement CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Supplement CDMO Market Share by Region (2020-2031)
Figure 33. China Supplement CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan Supplement CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea Supplement CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia Supplement CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India Supplement CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia Supplement CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Supplement CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Supplement CDMO Market Share by Country (2020-2031)
Figure 41. Mexico Supplement CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil Supplement CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Supplement CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Supplement CDMO Market Share by Country (2020-2031)
Figure 45. Turkey Supplement CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia Supplement CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE Supplement CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Biofarma Group Revenue Growth Rate in Supplement CDMO Business (2020-2025)
Figure 49. SFI Health Solutions Revenue Growth Rate in Supplement CDMO Business (2020-2025)
Figure 50. TCI Bio Revenue Growth Rate in Supplement CDMO Business (2020-2025)
Figure 51. Lonza Revenue Growth Rate in Supplement CDMO Business (2020-2025)
Figure 52. HERMES PHARMA Revenue Growth Rate in Supplement CDMO Business (2020-2025)
Figure 53. AGC Biologics Revenue Growth Rate in Supplement CDMO Business (2020-2025)
Figure 54. Vitaquest Revenue Growth Rate in Supplement CDMO Business (2020-2025)
Figure 55. Catalent Revenue Growth Rate in Supplement CDMO Business (2020-2025)
Figure 56. KD Pharma Group Revenue Growth Rate in Supplement CDMO Business (2020-2025)
Figure 57. Pharma Tech Industries Revenue Growth Rate in Supplement CDMO Business (2020-2025)
Figure 58. CordenPharma Revenue Growth Rate in Supplement CDMO Business (2020-2025)
Figure 59. Pierre Fabre Revenue Growth Rate in Supplement CDMO Business (2020-2025)
Figure 60. NutraPak USA Revenue Growth Rate in Supplement CDMO Business (2020-2025)
Figure 61. American Health Formulations Revenue Growth Rate in Supplement CDMO Business (2020-2025)
Figure 62. Alora Pharmaceuticals Revenue Growth Rate in Supplement CDMO Business (2020-2025)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Table 1. Global Supplement CDMO Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Small Molecule CDMO
Table 3. Key Players of Large Molecule CDMO
Table 4. Global Supplement CDMO Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Supplement CDMO Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Supplement CDMO Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Supplement CDMO Market Share by Region (2020-2025)
Table 8. Global Supplement CDMO Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Supplement CDMO Market Share by Region (2026-2031)
Table 10. Supplement CDMO Market Trends
Table 11. Supplement CDMO Market Drivers
Table 12. Supplement CDMO Market Challenges
Table 13. Supplement CDMO Market Restraints
Table 14. Global Supplement CDMO Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Supplement CDMO Market Share by Players (2020-2025)
Table 16. Global Top Supplement CDMO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Supplement CDMO as of 2024)
Table 17. Ranking of Global Top Supplement CDMO Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Supplement CDMO Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Supplement CDMO, Headquarters and Area Served
Table 20. Global Key Players of Supplement CDMO, Product and Application
Table 21. Global Key Players of Supplement CDMO, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Supplement CDMO Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Supplement CDMO Revenue Market Share by Type (2020-2025)
Table 25. Global Supplement CDMO Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Supplement CDMO Revenue Market Share by Type (2026-2031)
Table 27. Global Supplement CDMO Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Supplement CDMO Revenue Market Share by Application (2020-2025)
Table 29. Global Supplement CDMO Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Supplement CDMO Revenue Market Share by Application (2026-2031)
Table 31. North America Supplement CDMO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Supplement CDMO Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Supplement CDMO Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Supplement CDMO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Supplement CDMO Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Supplement CDMO Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Supplement CDMO Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Supplement CDMO Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Supplement CDMO Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Supplement CDMO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Supplement CDMO Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Supplement CDMO Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Supplement CDMO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Supplement CDMO Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Supplement CDMO Market Size by Country (2026-2031) & (US$ Million)
Table 46. Biofarma Group Company Details
Table 47. Biofarma Group Business Overview
Table 48. Biofarma Group Supplement CDMO Product
Table 49. Biofarma Group Revenue in Supplement CDMO Business (2020-2025) & (US$ Million)
Table 50. Biofarma Group Recent Development
Table 51. SFI Health Solutions Company Details
Table 52. SFI Health Solutions Business Overview
Table 53. SFI Health Solutions Supplement CDMO Product
Table 54. SFI Health Solutions Revenue in Supplement CDMO Business (2020-2025) & (US$ Million)
Table 55. SFI Health Solutions Recent Development
Table 56. TCI Bio Company Details
Table 57. TCI Bio Business Overview
Table 58. TCI Bio Supplement CDMO Product
Table 59. TCI Bio Revenue in Supplement CDMO Business (2020-2025) & (US$ Million)
Table 60. TCI Bio Recent Development
Table 61. Lonza Company Details
Table 62. Lonza Business Overview
Table 63. Lonza Supplement CDMO Product
Table 64. Lonza Revenue in Supplement CDMO Business (2020-2025) & (US$ Million)
Table 65. Lonza Recent Development
Table 66. HERMES PHARMA Company Details
Table 67. HERMES PHARMA Business Overview
Table 68. HERMES PHARMA Supplement CDMO Product
Table 69. HERMES PHARMA Revenue in Supplement CDMO Business (2020-2025) & (US$ Million)
Table 70. HERMES PHARMA Recent Development
Table 71. AGC Biologics Company Details
Table 72. AGC Biologics Business Overview
Table 73. AGC Biologics Supplement CDMO Product
Table 74. AGC Biologics Revenue in Supplement CDMO Business (2020-2025) & (US$ Million)
Table 75. AGC Biologics Recent Development
Table 76. Vitaquest Company Details
Table 77. Vitaquest Business Overview
Table 78. Vitaquest Supplement CDMO Product
Table 79. Vitaquest Revenue in Supplement CDMO Business (2020-2025) & (US$ Million)
Table 80. Vitaquest Recent Development
Table 81. Catalent Company Details
Table 82. Catalent Business Overview
Table 83. Catalent Supplement CDMO Product
Table 84. Catalent Revenue in Supplement CDMO Business (2020-2025) & (US$ Million)
Table 85. Catalent Recent Development
Table 86. KD Pharma Group Company Details
Table 87. KD Pharma Group Business Overview
Table 88. KD Pharma Group Supplement CDMO Product
Table 89. KD Pharma Group Revenue in Supplement CDMO Business (2020-2025) & (US$ Million)
Table 90. KD Pharma Group Recent Development
Table 91. Pharma Tech Industries Company Details
Table 92. Pharma Tech Industries Business Overview
Table 93. Pharma Tech Industries Supplement CDMO Product
Table 94. Pharma Tech Industries Revenue in Supplement CDMO Business (2020-2025) & (US$ Million)
Table 95. Pharma Tech Industries Recent Development
Table 96. CordenPharma Company Details
Table 97. CordenPharma Business Overview
Table 98. CordenPharma Supplement CDMO Product
Table 99. CordenPharma Revenue in Supplement CDMO Business (2020-2025) & (US$ Million)
Table 100. CordenPharma Recent Development
Table 101. Pierre Fabre Company Details
Table 102. Pierre Fabre Business Overview
Table 103. Pierre Fabre Supplement CDMO Product
Table 104. Pierre Fabre Revenue in Supplement CDMO Business (2020-2025) & (US$ Million)
Table 105. Pierre Fabre Recent Development
Table 106. NutraPak USA Company Details
Table 107. NutraPak USA Business Overview
Table 108. NutraPak USA Supplement CDMO Product
Table 109. NutraPak USA Revenue in Supplement CDMO Business (2020-2025) & (US$ Million)
Table 110. NutraPak USA Recent Development
Table 111. American Health Formulations Company Details
Table 112. American Health Formulations Business Overview
Table 113. American Health Formulations Supplement CDMO Product
Table 114. American Health Formulations Revenue in Supplement CDMO Business (2020-2025) & (US$ Million)
Table 115. American Health Formulations Recent Development
Table 116. Alora Pharmaceuticals Company Details
Table 117. Alora Pharmaceuticals Business Overview
Table 118. Alora Pharmaceuticals Supplement CDMO Product
Table 119. Alora Pharmaceuticals Revenue in Supplement CDMO Business (2020-2025) & (US$ Million)
Table 120. Alora Pharmaceuticals Recent Development
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
Table 124. Authors List of This Report
List of Figures
Figure 1. Supplement CDMO Picture
Figure 2. Global Supplement CDMO Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Supplement CDMO Market Share by Type: 2024 VS 2031
Figure 4. Small Molecule CDMO Features
Figure 5. Large Molecule CDMO Features
Figure 6. Global Supplement CDMO Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Supplement CDMO Market Share by Application: 2024 VS 2031
Figure 8. Solid Dosage Form Case Studies
Figure 9. Liquid Dosage Form Case Studies
Figure 10. Powder Case Studies
Figure 11. Others Case Studies
Figure 12. Supplement CDMO Report Years Considered
Figure 13. Global Supplement CDMO Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global Supplement CDMO Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Supplement CDMO Market Share by Region: 2024 VS 2031
Figure 16. Global Supplement CDMO Market Share by Players in 2024
Figure 17. Global Supplement CDMO Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 18. The Top 10 and 5 Players Market Share by Supplement CDMO Revenue in 2024
Figure 19. North America Supplement CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America Supplement CDMO Market Share by Country (2020-2031)
Figure 21. United States Supplement CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada Supplement CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Supplement CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Supplement CDMO Market Share by Country (2020-2031)
Figure 25. Germany Supplement CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France Supplement CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. Supplement CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy Supplement CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia Supplement CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Nordic Countries Supplement CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Supplement CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Supplement CDMO Market Share by Region (2020-2031)
Figure 33. China Supplement CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan Supplement CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea Supplement CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia Supplement CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India Supplement CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia Supplement CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Supplement CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Supplement CDMO Market Share by Country (2020-2031)
Figure 41. Mexico Supplement CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil Supplement CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Supplement CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Supplement CDMO Market Share by Country (2020-2031)
Figure 45. Turkey Supplement CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia Supplement CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE Supplement CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Biofarma Group Revenue Growth Rate in Supplement CDMO Business (2020-2025)
Figure 49. SFI Health Solutions Revenue Growth Rate in Supplement CDMO Business (2020-2025)
Figure 50. TCI Bio Revenue Growth Rate in Supplement CDMO Business (2020-2025)
Figure 51. Lonza Revenue Growth Rate in Supplement CDMO Business (2020-2025)
Figure 52. HERMES PHARMA Revenue Growth Rate in Supplement CDMO Business (2020-2025)
Figure 53. AGC Biologics Revenue Growth Rate in Supplement CDMO Business (2020-2025)
Figure 54. Vitaquest Revenue Growth Rate in Supplement CDMO Business (2020-2025)
Figure 55. Catalent Revenue Growth Rate in Supplement CDMO Business (2020-2025)
Figure 56. KD Pharma Group Revenue Growth Rate in Supplement CDMO Business (2020-2025)
Figure 57. Pharma Tech Industries Revenue Growth Rate in Supplement CDMO Business (2020-2025)
Figure 58. CordenPharma Revenue Growth Rate in Supplement CDMO Business (2020-2025)
Figure 59. Pierre Fabre Revenue Growth Rate in Supplement CDMO Business (2020-2025)
Figure 60. NutraPak USA Revenue Growth Rate in Supplement CDMO Business (2020-2025)
Figure 61. American Health Formulations Revenue Growth Rate in Supplement CDMO Business (2020-2025)
Figure 62. Alora Pharmaceuticals Revenue Growth Rate in Supplement CDMO Business (2020-2025)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Household Embroidery Machines Market Research Report 2025
Jul 18, 25
Global Residential Electric Underfloor Heating Market Research Report 2025
Jul 18, 25
Global Commercial Electric Underfloor Heating Market Research Report 2025
Jul 18, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232